Cargando…

Metabolic and respiratory consequences of a glucose load in a hypoxic patient with cystic fibrosis.

Detalles Bibliográficos
Autores principales:	Elborn, J. S., Jagoe, T., Shale, D. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Ulster Medical Society 1992
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2448941/ https://www.ncbi.nlm.nih.gov/pubmed/1481313

Ejemplares similares

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Modulator treatment for people with cystic fibrosis: moving in the right direction
por: Elborn, J. Stuart
Publicado: (2020)

Infection control and the significance of sputum and other respiratory secretions from adult patients with cystic fibrosis
por: Moore, John E, et al.
Publicado: (2004)

Protein biomarkers in cystic fibrosis research: where next?
por: Pattison, Sally H, et al.
Publicado: (2010)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Digital healthcare in cystic fibrosis. Learning from the pandemic to innovate future care (Commentary)()
por: Elborn, J Stuart
Publicado: (2021)

Targeted therapies to improve CFTR function in cystic fibrosis
por: Brodlie, Malcolm, et al.
Publicado: (2015)

Organisms isolated from adults with Cystic Fibrosis
por: McManus, Terence E, et al.
Publicado: (2004)

MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis
por: Vallières, Emilie, et al.
Publicado: (2016)

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
por: Quittner, Alexandra L, et al.
Publicado: (2016)

Resistance Development of Cystic Fibrosis Respiratory Pathogens When Exposed to Fosfomycin and Tobramycin Alone and in Combination under Aerobic and Anaerobic Conditions
por: McCaughey, Gerard, et al.
Publicado: (2013)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022)

Editorial: Co-Infection and Consequences in Cystic Fibrosis
por: Kahl, Barbara C., et al.
Publicado: (2022)

Erratum to “Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis”
por: Hirche, T. O., et al.
Publicado: (2015)

Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis
por: Hirche, T. O., et al.
Publicado: (2014)

Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences
por: Eng, Alexander, et al.
Publicado: (2021)

Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis
por: Elborn, JS, et al.
Publicado: (2016)

Lumacaftor/ivacaftor in cystic fibrosis: effects on glucose metabolism and insulin secretion
por: Colombo, C., et al.
Publicado: (2021)

Impaired Fasting Glucose in Cystic Fibrosis
por: Frohnert, Brigitte I., et al.
Publicado: (2010)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

New strategies of physical activity assessment in cystic fibrosis: a pilot study
por: Savi, Daniela, et al.
Publicado: (2020)

Shortened Lung Clearance Index is a repeatable and sensitive test in children and adults with cystic fibrosis
por: Hannon, David, et al.
Publicado: (2014)

Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections
por: Fluit, Ad C., et al.
Publicado: (2022)

The role of respiratory viruses in cystic fibrosis
por: Wat, Dennis, et al.
Publicado: (2008)

Viral respiratory infections in cystic fibrosis
por: van Ewijk, Bart E., et al.
Publicado: (2005)

An inflammatory Signature of Glucose Impairment in Cystic Fibrosis
por: Montemari, Anna Lisa, et al.
Publicado: (2022)

A Practical Approach to Glucose Abnormalities in Cystic Fibrosis
por: Jones, Gregory C., et al.
Publicado: (2016)

Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His
por: Shteinberg, Michal, et al.
Publicado: (2017)

1078. Expectations and Attitudes Toward Antimicrobial Stewardship Among Cystic Fibrosis Care Providers
por: Bullington, Wendy, et al.
Publicado: (2019)

Seasonal respiratory virus testing in management of adult cystic fibrosis patients
por: Gohil, S., et al.
Publicado: (2019)

Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis
por: Widger, John, et al.
Publicado: (2012)

68 Respiratory viral detection in children with cystic fibrosis (CF)
por: Tješić-Drinković, I., et al.
Publicado: (2015)

Editorial: Fungal Respiratory Infections in Cystic Fibrosis
por: Papon, Nicolas, et al.
Publicado: (2021)

Sphingobacterium respiratory tract infection in patients with cystic fibrosis
por: Lambiase, Antonietta, et al.
Publicado: (2009)

Respiratory Fungal Diseases in Adult Patients With Cystic Fibrosis
por: Delfino, Emanuele, et al.
Publicado: (2019)

Viral infections of the respiratory tract in patients with cystic fibrosis
por: Przyklenk, B., et al.
Publicado: (1988)

Impaired glucose tolerance and indeterminate glycemia in cystic fibrosis
por: Kasim, Nader, et al.
Publicado: (2021)

Forced oscillations and respiratory system modeling in adults with cystic fibrosis
por: Lima, Adma N, et al.
Publicado: (2015)

Glucose tolerance in Canadian and French cystic fibrosis adult patients
por: Reynaud, Quitterie, et al.
Publicado: (2019)

Method for detection of respiratory viruses in the sputa of patients with cystic fibrosis
por: Punch, G., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_2hu1kdetihhdjsn5goq54s7c9o